Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide

The major determinant of the decline in lung function, quality of life, and the increased mortality risk in patients with COPD is represented by severe acute exacerbations of the disease, that is, those requiring patients’ hospitalization, constituting a substantial social and health care burden in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantero, Marco, Radovanovic, Dejan, Santus, Pierachille, Blasi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072677/
https://www.ncbi.nlm.nih.gov/pubmed/30104872
http://dx.doi.org/10.2147/COPD.S147484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072677/
https://www.ncbi.nlm.nih.gov/pubmed/30104872
http://dx.doi.org/10.2147/COPD.S147484

Ejemplares similares